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Abstract
Introduction Postoperative delirium (POD) is a common
complication in elderly patients, characterised by a
fluctuating course of altered consciousness, disordered
thinking and inattention. Preliminary research has linked
POD with persistent cognitive impairment and decreased
quality of life. However, these findings maybe confounded
by patient comorbidities, postoperative complications
and frailty. Our objective is to determine whether POD is
an independent risk factor for persistent impairments in
attention and executive function after elective surgery.
Our central hypothesis is that patients with POD are more
likely to have declines in cognition and quality of life 1 year
after surgery compared with patients without POD. We aim
to clarify whether these associations are independent of
potentially confounding factors. We will also explore the
association between POD and incident dementia.
Methods and analysis This study will recruit 200
patients from the ongoing Electroencephalography
Guidance of Anesthesia to Alleviate Geriatric Syndromes
(ENGAGES) study. Patients who live ≤45 miles from the
study centre or have a planned visit to the centre 10–16
months postoperatively will be eligible. Patients with POD,
measured by the Confusion Assessment Method, will be
compared with patients without delirium. The primary
outcome of cognitive function and secondary outcomes
of quality of life and incident dementia will be compared
between cohorts. Cognition will be measured by Trails
A and B and Stroop Color and Word Test, quality of life
with Veteran’s RAND 12-item Health Survey and incident
dementia with the Short Blessed Test. Multivariable
regression analyses and a Cox proportional hazards
analysis will be performed. All results will be reported with
95% CIs and α=0.05.
Ethics and dissemination The study has been approved
by the Washington University in St. Louis Institutional
Review Board (IRB no 201601099). Plans for dissemination
include scientific publications and presentations at
scientific conferences.
Trial registration number NCT02241655.

Strengths and limitations of this study
►► Postoperative intermediate term cognitive function

and quality of life are important patient-centred
outcomes.
►► Analysis will include salient patient characteristics,
including preoperative cognition, comorbid conditions and frailty.
►► Study sample will consist of an understudied population in clinical research.
►► Potential for loss to follow-up and non-response
bias.
►► We cannot determine whether cognitive function deviates from the preoperative trend, without multiple
preoperative cognitive assessments to establish a
trajectory.

Background
Since Bedford’s 1955 case series suggesting
an association between surgical intervention
and cognitive impairment, there has been
growing concern among the public that
cognitive decline is a common consequence
of surgery.1 This pervasive view continues to
concern patients and their families, fuelled
by anecdotal evidence and media coverage.
Postoperative cognitive decline (POCD) has
been a growing topic for scientific investigation after several studies were published by
the International Study of Post-Operative
Cognitive Dysfunction group. While several
influential studies demonstrated early POCD
lasting up to 3 months, the persistence of this
cognitive decline has been controversial.2–6
Importantly, the population of Americans
older than 60 years is projected to double
over the next 30 years,7 and many will require
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surgery. Acute and long-term cognitive changes related
to surgical intervention are particularly distressing to
patients and their families. Therefore, clarification of
cognitive outcomes would assist patients and practitioners
in making an informed decision about the relative risks
and benefits of proceeding with elective surgery.
Literature search and review
A systemised literature review was conducted with the
help of a librarian experienced in a systemic review (see
Acknowledgements). Ovid Medline was searched for
studies published between 1981 and September 2016
using the query: Postoperative or after surgery AND
Delirium AND Cognitive function or dementia AND
Elderly AND Long-term or intermediate term or follow
up or cohort studies or retrospective studies. Articles in
English or with English translation were considered. JZC
and RT reviewed the 301 search results and found 28 articles that were relevant to our clinical question. Out of the
28 relevant articles, 21 (75%) showed significant result in
the relationship between postoperative delirium (POD)
and intermediate-term to long-term cognitive decline
(see online supplementary appendix A). These seem to
suggest a high pretest probability in studying the ability
of POD to predict intermediate-term cognitive decline.
However, these studies are heterogeneous in the study
design, selected surgical patient population and outcome
measurement tools complicating the synthesis of the
systemic search to draw conclusions.
POD is a common complication for surgical patients
over the age of 60 years.8 It is a neurological syndrome
characterised by acute and fluctuating disturbances in
awareness and attention that represent a change from
baseline; in addition to these cardinal features, the
diagnosis of delirium requires at least one additional
cognitive symptom and the absence of medical conditions that might explain these disturbances. Although
usually transient, POD has been associated with several
salient adverse outcomes, including mortality, prolonged
intensive care unit (ICU) stay and persistent cognitive
decline.9–12 One prospective cohort study of cardiac
surgery patients suggested that patients experiencing
POD had prolonged cognitive impairment at 1 year and
those with a longer duration of delirium had slower
recovery.12 However, after adjusting for baseline differences in cognitive function, there was no significant
difference compared with controls. The same study also
demonstrated that mild cognitive impairment preoperatively may predispose patients to delirium; thus, POD
may be exposing patients who are already experiencing
subclinical cognitive decline or those who have an underlying vulnerability to cognitive decline. Another study
in orthopaedic surgery patients found no association
between POD and cognitive decline at 3 months.13 While
several studies have suggested that POCD can persist past
6 months after surgery,2 14 others have demonstrated a
transient early decline with later recovery.4 5 Furthermore,
there is conflicting evidence regarding the long-term
2

cognitive trajectories of postoperative patients, with some
suggesting overall improvement and others suggesting
overall decline.15 16 POD has been posited as a risk factor
for lasting decline; however, few articles have addressed
the association between POD and persistent POCD
(arbitrarily defined as lasting >6 months). A prospective
matched controlled survey with an average of 30 month
follow-up demonstrated that dementia or mild cognitive
impairment was diagnosed in 77.8% of the surviving hip
surgery patients with POD, almost doubling the 40.9%
rate of control patients (relative risk=1.9, 95% CI 1.1 to
3.3). However, the study was underpowered to evaluate
the long-term cognitive function, as the power calculation was based on the original study and no intermediate
assessments were made to track patients’ cognitive function.17 Another prospective cohort study followed patients
over 36 months and found that patients with POD initially
had cognitive decline with a transient recovery, but then
exhibited an accelerated pace of long-term cognitive
decline when compared with controls.18 Overall, the
results of these studies suggest an association between
POD and persistent cognitive impairment; however,
compelling data supporting an independent association
are lacking. Many of these studies also do not consider
the duration of delirium, which may portend long-term
cognitive decline.19 20
Pre-existing dementia or cognitive impairment is a
known risk factor for POD,8 and several studies suggest
an association between POD and dementia. One study in
elderly orthopaedic surgery patients reported a relative
risk of dementia in patient with POD of 10.5 compared
with those without POD.21 A recent study demonstrated
a similar association in elderly cardiac surgery patients.22
However, it remains unclear whether POD causes, accelerates or signifies an underlying vulnerability to cognitive
impairment, and thus further investigation is warranted.
In addition to cognitive outcomes, quality of life and
functional capacity are also important patient-centred
outcomes that require further investigation. While one
study found that elderly surgical patients tended to have
long-term cognitive and functional decline compared
with non-surgical patients,23 few studies have examined
the association between cognitive function and quality
of life or activities of daily living. One prospective study
over a 10-month period demonstrated that delirium was
an independent risk factor for becoming dependent for
personal activities of daily living after ICU discharge (OR
2.188, P<0.046) and that patients with POD also demonstrated a greater decline in Short-Form-36 domains after
discharge, especially in physical function, vitality and social
function.24 However, this study could not draw conclusions regarding cognitive function due to lack of data.
Kastaun et al reported perceived impairment in ability
to perform activities of daily living 1 year after surgery,
however did not detect significant cognitive decline at
that time.25 It remains unclear whether cognitive decline
results in impaired functional capacity or decreased
quality of life. In fact, given the variable definitions of
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POCD, data from previous studies are difficult to interpret. As many of the deficits found in neuropsychiatric
testing are subtle, it is possible that detected cognitive
impairment has no clinically significant impact on these
patient-centred outcomes. Instead of using an arbitrary
threshold to dichotomise cognitive function as normal or
impaired, it would be more informative to correlate these
outcomes with cognitive function as a continuous variable
or stratified into multiple groups.
At our institution, patient reported postoperative
outcomes are gathered as part of the Systematic Assessment and Targeted Improvement of Services Following
Yearlong Surgical Outcomes Surveys (SATISFY-SOS)
initiative (NCT02032030). Additionally, the ongoing
randomised controlled trial, Electroencephalography
(EEG) Guidance of Anesthesia to Alleviate Geriatric
Syndromes (ENGAGES) study, is evaluating patients for
POD.26 Using the scaffold provided by these studies,
we aim to identify whether delirium is an independent
predictor for intermediate-term cognitive function and
quality of life.
Justification
The population of older adults is projected to double
over the next 30 years, and many will undergo elective
surgery with the hope of overall improvement in health
and quality of life. POD is a common and potentially
preventable complication; thus, clarification of its association with persistent declines in cognition and quality of
life will inform perioperative care. Prior studies have not
demonstrated an association independent of pre-existing
patient characteristics and perioperative course. The
proposed study addresses the methodological concerns
in current literature by: (1) objectively evaluating attention and executive function with validated cognitive tests,
(2) obtaining measurements of baseline cognitive function, (3) conducting statistical analysis which includes
important potential confounding factors including frailty
measures and (4) sampling from an unselected surgical
population. Given that delirium is predominantly a
disorder of attention and executive function, we will focus
our investigation on these cognitive domains. The results
of this study will contribute to the broader understanding
of postoperative cognitive changes and may help identify
and provide therapies for susceptible patients earlier to
ultimately improve outcomes.
As part of the ENGAGES study, patients have been
enrolling since January 2015, with 804 patients enrolled
thus far. Over the last year, the ENGAGES research team
has enrolled approximately 35 patients/month, and has
gathered baseline cognitive data on a majority of participants. Preliminary screening suggests about 65% of those
enrolled in ENGAGES are eligible for the current study.
Anticipating that half of those contacted will enrol, we
expect to assess 10–15 patients/month. The scaffold of
ENGAGES and trained study members make this substudy
highly feasible.

Specific aims
Specific aim 1
Determine whether the incidence and duration of POD
predict worse performance on specific cognitive tests at
approximately 1 year after surgery.
We hypothesise that POD is independently associated
with poorer performance on tests of attention and executive function at 1 year after surgery and that patients
with a longer duration of delirium will have more marked
cognitive decrement. We will conduct a regression analysis, including likely contributory variables, to assess the
association between delirium and cognitive decline at
approximately 1 year.
Specific aim 2
Evaluate whether the incidence and duration of POD
predict worse quality of life at approximately 1 year
postoperatively.
We hypothesise that POD is independently associated
with decreased quality of life 1 year after surgery and that
patients with a longer duration of delirium will have more
marked decrease in health-related quality of life. We will
conduct a regression analysis, including likely contributory variables, to assess the association between delirium
and health-related quality of life at approximately 1 year.
Specific aim 3
Explore whether patients who experience POD are more
likely to develop dementia within approximately one to
2 years of their surgery.
We hypothesise that POD is independently associated
with incident dementia 1–2 years after surgery. We will
conduct a Cox proportional hazards regression, including
likely contributory variables, to assess the rate of incident
dementia approximately 1–2 years after surgery.

Study design
This prospective cohort study is prespecified substudy
of the ENGAGES study. The ENGAGES study is a
randomised clinical trial enrolling approximately 1200
patients aged 60 years and older who will undergo elective major surgery at Barnes Jewish Hospital (BJH),
St. Louis, Missouri, USA.
The parent trial will recruit patients primarily from
the Center for Preoperative Assessment and Planning
(CPAP) clinic. Details regarding ENGAGES recruitment
and methods have been previously published.26 Enrolment in the SATISFY-SOS study,27 is an inclusion criteria
for participation in ENGAGES. As part of ENGAGES,
participants will complete a comprehensive baseline
assessment including cognitive tests, frailty measures and
screening for delirium and dementia. Postoperatively,
patients will have daily evaluations for delirium during
the hospital stay. The current study will retrospectively
identify 200 participants who reside within approximately 45 miles from the hospital or those who have a
planned visit to the hospital between 10 and 16 months
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postoperatively. Patients diagnosed with delirium postoperatively will be compared with those without delirium. A
prospective intermediate-term postoperative assessment
will be conducted by a research team member blinded to
whether the patient developed POD.
Study groups
The target population for this study is patients who
underwent preoperative assessment for elective surgery
at the CPAP clinic at BJH in St. Louis, Missouri, USA. The
ENGAGES study is enrolling 1232 patients who are already
enrolled in the STATISFY-SOS study. Inclusion criteria
include patients aged 60 years and older, who are competent to provide informed consent and who are undergoing major elective surgery under general anaesthesia
with a potent volatile anaesthetic agent that requires a
minimum stay of 2 days postoperatively (ie, open cardiac
surgery, open thoracic surgery, major vascular surgery,
intra-abdominal surgery, open gynaecological surgery,
open urological surgery, major orthopaedic surgery,
open hepatobiliary surgery and major ear, nose and
throat surgery). The ENGAGES study has minimal exclusion, as there are no absolute contraindications to EEG
monitoring. Exclusion criteria include neurosurgical
procedures, preoperative delirium, patients who are
unable to participate adequately in delirium screening,
including those who are blind, deaf, illiterate or not
fluent in English, patients with a history of intraoperative awareness during intended general anaesthesia and
patients who had a second surgery planned within 5 days
after the index surgery. This prospective study will enrol
200 patients who are already enrolled in the ENGAGES
and SATISFY-SOS studies (see online supplementary
appendix B). In addition to previously described inclusion and exclusion criteria, participants will be included
in this study if their home residence is ≤45 miles from
BJH or they have a planned visit to the hospital within the
specified timeframe. Patients who have not completed
the baseline cognitive assessment with Trails A, Trails B
and the Stroop Color and Word Test will also be excluded
from this study.
Recruitment
As part of the SATISFY-SOS study, patients have given
informed consent to be contacted by Washington University for follow-up of health-related outcomes up to a year
after surgery. Eligible participants will be identified by
chart review and query of the ENGAGES Research Electronic Data Capture (REDCap) database. A member of
the research team will contact potential participants by
telephone approximately 10–16 months after surgery for
enrolment in this study. Patients may refuse participation
in the study. If patients agree to participation, written
consent will be obtained when the patient comes in for
assessment, prior to any data collection. Patients will then
be prospectively evaluated with assessments of cognition,
4

quality of life and frailty measures, which are described in
the Data collection section. Meal vouchers will be provided
for participation. Patients residing within approximately
45 miles of the hospital, who are willing to participate in
the study, but unable or unwilling to come to the study
centre will be offered assessment at home by a member
of the research team. Additionally, ENGAGES patients
who have not completed a 1 year dementia screening will
be contacted by telephone approximately 18–24 months
after surgery. Phone consent will be obtained to complete
dementia screening over the telephone. Participants may
refuse to participate.

Data
Data collection
Routinely obtained baseline assessment in the CPAP
clinic includes demographic information, a detailed
medical history, surgical history, medications and physical examination. As part of SATISFY-SOS and ENGAGES,
baseline assessment using the Barthel Index, Veteran’s
RAND 12-item Health Survey (VR-12), Eight-item Interview to Differentiate Aging and Dementia, Short Blessed
Test (SBT), alcohol sniff test and Personal Health Questionnaire Depression Scale will be performed. Baseline
cognitive function will be evaluated by the ENGAGES
team with the Trails A and B, and the Stroop Color and
Word Test. Some patients may complete computer-based
cognitive testing with the National Institutes of Health
(NIH) toolbox at baseline (described below). Additionally, frailty will be assessed using grip strength, Timed
Up and Go (TUG) test and obtaining fall history at baseline. Participants will have daily delirium assessments
by trained researchers with the Confusion Assessment
Method in the postoperative period for the duration of
their hospital stay. Data collected by the ENGAGES team
will be entered into the Washington University School of
Medicine REDCap application.18 Perioperative data will
be retrieved from the hospital’s perioperative electronic
medical record (EMR; Metavision by iMDsoft, Needham,
Massachusetts, USA). High-fidelity perioperative data
are routinely captured from our EMR to an SQL server
(Microsoft, Redmond, Washington, USA) database.
These data include Bispectral Index (BIS) values, EEG
burst suppression durations, laboratory data, intraoperative medications, physiological readings and postoperative recovery parameters. All the data for SATISFY-SOS are
integrated from various data sources and are stored in a
single data repository housed in the Department of Anesthesiology at Washington University. Table 1 contains
details regarding variables to be collected for the study.
Cognition
The primary outcome in this study will be a composite
score from three cognitive tests evaluating attention
and executive function: Trails A, Trails B and Stroop
Color and Word Test. These cognitive tests will be
repeated approximately 1 year after surgery to evaluate
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10 Categories
Dichotomous

Type of surgery
ENGAGES randomisation

Medical record and survey

Dichotomous
Dichotomous

Depression

Current, past, never

Preoperative vascular disease

CPAP assessment

Ordinal, 0–100

Functional dependence

Smoking status

CPAP assessment
Research team member

Medical record

Baseline
Day of surgery

NA
NA

No

Yes

Baseline and 1 year
Baseline

NA

Yes

NA

NA

NA

Yes

Yes

Yes

Yes

Yes

Yes

Yes

No

NA

Baseline

Baseline and 1 year

Baseline

Research team member

Baseline

Medical record
Research team member

<High school, high school, >high
school

Baseline

Baseline and 1 year

Baseline and 1 year

Dichotomous

Medical record

Survey

Survey

Education level

Dichotomous

Dementia

Baseline and 1 year
Baseline and 1 year

Sex

Continuous

Mental quality of life

Survey

Research team member

Continuous

Continuous

Physical quality of life

Baseline and 1 year

Baseline and 1 year

Baseline

1 year

Baseline

Age

Continuous

Stroop Color and Word Test

Research team member

Research team member

Anaesthesia record

Survey and medical record

Survey

ASA, American Society of Anesthesiologists; CPAP, Center for Preoperative Assessment and Planning; ENGAGES, Electroencephalography Guidance of Anaesthesia to Alleviate Geriatric
syndromes; NA, not applicable.

Confounder

Continuous

Trails B

Ordinal, 1–6
Continuous

ASA physical status

Trails A

0, 1, 2, 3+

Outcome

Dichotomous

Postoperative complications

Yes

History of falls

Research team member

Yes

Baseline and 1 year

Continuous

Timed Up and Go

Research team member

Yes

Continuous

Grip strength

NA

Yes

Standardised tool?

Baseline and 1 year

Baseline

0, 1, 2, 3+

Charlson Comorbidity Index

Medical record

Inpatient postoperative hospital
days
Inpatient postoperative hospital
days

Time

Postoperative delirium incidence Dichotomous (present or absent) ENGAGES postoperative
assessment
Postoperative delirium duration Categorical
ENGAGES postoperative
(<3 days or ≥3 days)
assessment

Source

Explanatory

Form

Variable

Variables to be collected for the study

Type

Table 1
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intermediate term cognitive function. The research team
member performing the assessments will be blinded to
whether the patient developed POD. In addition to the
above tests, this study proposes to use the Cognition
Battery of the NIH Toolbox Assessment of Neurological
and Behavioural Function (http://www.nihtoolbox.org).
The NIH Toolbox Cognition Battery (Feinberg School
of Medicine, Northwestern University, Chicago, IL), is a
comprehensive yet concise standardised computer-based
assessment battery; we plan to include tasks to evaluate
attention (Flanker Inhibitory Control and Attention
Test), episodic memory (Picture Sequence Memory Test)
and executive function (Dimensional Change Card Sort
Test and Flanker Inhibitory Control and Attention Test).
Patients will complete the NIH Toolbox Cognition tests
above, which takes approximately 10 min to complete.
The NIH Toolbox Cognition Battery has been validated
for use across a wide range of ages.28 29 Self-reported cognitive function will be evaluated by the Patient Reported
Outcomes Measurement Information System (PROMIS).
PROMIS, funded by the NIH, is a set of highly reliable,
valid, flexible, precise and responsive assessment tools
that measure patient–reported health status. PROMIS
V.1.0-Applied Cognition-General Concerns-Short Form
4a is comprised four questions about thinking and cognition. PROMIS V.1.0-Applied Cognition-Abilities-Short
Form 4a is comprised four questions about memory. Evaluation for dementia with the SBT will be completed for
all patients at baseline, and again between 1 and 2 years
after surgery. The SBT has been shown to have 95% sensitivity for detecting cognitive dysfunction when compared
with the Mini-Mental State Examination, and can be
administered in approximately 3 min, making it an excellent screening tool.30

Frailty
Information regarding weight loss, endurance and physical activity level are routinely collected in the preoperative clinic and as part of SATISFY-SOS. We will also
measure grip strength and the TUG test. Grip strength
will be assessed with three measurements in the dominant
hand using a Jamar handheld dynamometer (Lafayette
Instruments, Lafayette, Indiana, USA). Maximal grip
strength will be selected for analysis.
Data management
A customised database has been developed to facilitate
data management for this study using the REDCap system.
REDCap is a secure web-based data capture system available to research groups receiving support from the Institute of Clinical and Translational Sciences at Washington
University. It is maintained by the Washington University Division of Biostatistics with multiple capabilities to
simplify data management and analysis. These include
intuitive data entry, data audit and tracking, import of
externally sourced data and automated data export for
analysis. REDCap requires unique user identification and
password combinations for secure access.

Quality of life
As part of the ongoing SATISFY-SOS study, patient
self-reported health-related quality of life information
will be assessed through the VR-12 at baseline (preoperatively) and also 1 year after surgery. The VR-12 was
derived from the Veterans RAND 36 Item Health Survey
(VR-36) and contains 12 items relating to quality of life,
including physical and mental health, as well as specific
questions about functional status. Physical and Mental
Health Summary Scores will be calculated. The VR-12
has been validated and is widely applied as a metric
for tracking health-related quality of life in the United
States.31

Statistical consideration
Sample calculations
For specific aims 1 and 2, sample size calculations have
been performed using G*POWER V.3.0.10. Power analysis for a multiple regression with 15 predictors was
conducted to determine a sufficient sample size using an
α of 0.05, a power of 0.9 and a medium effect size (f2=0.1).
Based on the aforementioned assumptions, the desired
sample size is 130 patients. We will plan to recruit 200
patients, which will increase the power for the primary
outcome and prevent overfitting of the regression model.
For specific aim 3, sample size calculation has been
performed using PS V.3.1.2. Based on results of a previously published meta-analysis of four studies investigating the use of BIS-guided anaesthetic administration,
we conservatively assume an incidence of POD of 25%.
A previous study has reported the median age at the
onset of dementia to be approximately 84 years old.32 To
detect a HR of 2.0 in patients with delirium compared
with those without delirium, with 80% power and
α=0.05, we will need 516 patients (129 in the delirium
group, and 387 in the control group). To account for a
10% attrition rate, we will recruit 570 patients.

Functional status
We will assess functional status with the Barthel index for
Activities of Daily Living and Lawton Instrumental Activities of Daily Living Scale. The Barthel Index is a measure
of patient performance in 10 activities comprised of eight
questions about personal care and two questions about
mobility. The Lawton Scale assesses independent living
skills in eight areas of function.

Statistical analysis
We will perform and report descriptive statistics (mean
and SD) for all variables between patients with and
without the diagnosis of POD. Descriptive statistics
will include χ2 tests for categorical variables, Student’s
t-test for normally distributed continuous variables and
Mann-Whitney U test for non-parametric continuous
variables.
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Specific aim 1
Determine whether the incidence and duration of POD
predict worse performance on specific cognitive tests at
approximately 1 year after surgery.
The primary endpoint of our analysis is cognitive function 1 year after surgery, as measured by the Trails A and
B and the Stroop Color and Word Test. Z-scores will be
calculated for performance for each test and combined
to form a composite measure. Multivariable regression
analysis will be used to determine whether the development of POD is a predictor variable for cognitive function, independent from other possible contributory
factors. POD will be entered as two categorical variables:
for incidence (present or absent) and for duration (<3
days POD or ≥3 days POD). The following variables will
be included in the model: age, sex, American Society of
Anesthesiologists (ASA) physical score, and Charlson
Comorbidity Index. The following known or suggested
risk factors cognitive decline will also be included in the
model: baseline cognitive function, education level, type
of surgery, randomisation group, preoperative depression, preoperative vascular disease, postoperative complications, composite score on frailty tests and a history of
falls. We will use a model with backward elimination to
avoid exclusion of predictors with suppressor effects.
While cognition will be entered as a continuous variable,
we will consider a change of 1 SD in cognitive score as a
minimal clinically important difference.
Specific aim 2
Evaluate whether the incidence and duration of POD
predict worse quality of life at approximately 1 year
postoperatively.
The primary endpoint of our analysis is quality of life
1 year after surgery, as measured by the change in VR-12
score between preoperative and postoperative assessments. Again, a multivariable regression analysis will be
performed to evaluate whether the development of POD
is an independent predictor variable for the change in
quality of life. POD will be entered as two categorical variables: for incidence (present or absent) and for duration
(<3 days POD or ≥3 days POD). The following variables
will be included in the model: age, sex, ASA physical
score, Charlson Comorbidity Index, type of surgery,
randomisation group, preoperative depression, preoperative vascular disease, postoperative complications, cognitive function, composite score on frailty tests and a history
of falls. As above, we will use a model with backward elimination, to avoid exclusion of predictors with suppressor
effects. Previous work by our group has calculated the
minimal clinically important difference for overall VR-12
quality of life to be 1.4 for improvement and 3.6 for
deterioration.33
For the above aims, we expect this study to be limited
by loss to follow-up, estimated to be 50%. Those lost to
follow-up are likely to have more severe disease or deterioration in health. In order to determine the influence
of missing data in our analysis, we will also conduct a

sensitivity analysis. We will calculate the average cognition
scores of those who declined. We will repeat the above
models including missing subjects, assuming all patients
who did not participate had cognitive decline, quantified
by the average calculated from participants above. Additionally, to examine whether our sample selection method
may bias the results, we will compare baseline characteristics of those ENGAGES patients who were eligible for our
study with those who were not eligible.
Specific aim 3
Explore whether patients who experience POD are
more likely to become demented within approximately
1–2 years of their surgery.
The primary endpoint of our analysis is incident
dementia. A Cox proportional hazards regression will be
used to explore the likelihood of incident dementia associated with POD. POD will be entered as a dichotomous
variable (absent or present). The following variables will
be included in the model: age, sex, ASA physical score,
Charlson Comorbidity Index, preoperative cognitive
function, type of surgery, randomisation group, preoperative depression, preoperative vascular disease, postoperative complications, and composite score on frailty tests
and a history of falls.
All statistical analyses will be performed using SAS,
V.9.4. All other tests will be two sided. By arbitrary convention, all tests will be two sided and considered statistically
significant at P<0.05, and all results will be presented with
estimates and 95%CIs.
Prespecified additional analyses and substudies
The primary aim of this study is to determine whether
POD predicts intermediate-term cognitive impairment.
However, as a substudy of ENGAGES and SATISFY-SOS,
several other clinically relevant outcomes can be explored
as well. SATISFY-SOS systematically collects detailed information regarding patient-centred outcomes, including
patient perceived cognition. Correlation between performance on neurocognitive testing and patient perceived
cognition would be interesting and useful clinically.
Furthermore, the information regarding patients’ characteristics will allow exploration of risk factors for intermediate-term cognitive impairment. To investigate effects on
memory, we will perform a secondary analysis comparing
the results of the SBT. Lastly, as part of ENGAGES, some
patients will have baseline NIH Toolbox cognitive testing,
allowing description of long-term cognitive trajectories as
evaluated by these tests.
Limitations
This study contains several limitations. First, of most
concern is the potential for non-response bias if patients
who do not participate are not a random subset of those
contacted. We will attempt to minimise the non-response rate by offering to visit patients at their homes if
patients are unwilling to come to the study centre. We
expect that those lost to follow-up would be more likely to
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have more severe disease or health deterioration, potentially affecting cognitive function. We will thus conduct
appropriate sensitivity analyses to determine how missing
outcomes data could alter the findings of our study.
Second, with an observational study, we cannot establish a causal relationship between POD and persistent
declines in cognitive and quality of life. If an independent relationship is found, we shall not be able to disambiguate whether POD in some way causes persistent
decline in these outcomes, or whether it is a sign of
underlying vulnerability. However, since it is not possible
to randomise patients to experience delirium, this limitation might be inevitable. Third, since patients in this study
are recruited from a single tertiary care centre, the study
sample may not be representative of surgical patients in
general. While patients from a tertiary care centre tend to
have higher comorbid disease burden than the general
surgical population, including comorbidities in the statistical model will account for these differences. Finally,
while we have baseline cognitive assessments, we do not
have preoperative cognitive trajectories, and thus cannot
determine whether the results of cognitive function tests
are a deviation from the preoperative trend.

after article publication. This study protocol, the statistical
analysis plan and analytic code will also be available.
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Compliance
Subject compliance
The exposure of this study is postoperative delirium,
so no monitoring of exposure compliance is necessary.
Methods to improve completion of 1 year cognitive testing
are described in the Limitations section.
Withdrawal of subjects
Subjects may be withdrawn from the study only if
requested by the patient. The reason for withdrawal is
recorded by the team’s clinical project specialist.
Ethical considerations
Written, informed consent is obtained from all participants. As described in the Study groups section, no
special allowances are made for patients who are blind,
deaf, illiterate or not fluent in English. Participants may
withdraw from the study at any time.
Finance and insurance
Since this study involves only cognitive testing and surveys,
it involves no more than minimal risk to the patients.
Finance details, insurance details and cover for negligent
and non-negligent harm are, therefore, not relevant in
this study.
Reporting and dissemination
Results of this study will be published in a scientific journal.
Participants will only be notified individually if discoveries
are made that directly impact their health. We intend to
make deidentified individual participant data used to obtain
the results reported from this study available to researchers
providing a study proposal between 3 months and 5 years
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